ZA904599B - Stable freeze dried polyhematoporphyrin ether/ester composition - Google Patents

Stable freeze dried polyhematoporphyrin ether/ester composition

Info

Publication number
ZA904599B
ZA904599B ZA904599A ZA904599A ZA904599B ZA 904599 B ZA904599 B ZA 904599B ZA 904599 A ZA904599 A ZA 904599A ZA 904599 A ZA904599 A ZA 904599A ZA 904599 B ZA904599 B ZA 904599B
Authority
ZA
South Africa
Prior art keywords
freeze dried
ester composition
stable freeze
polyhematoporphyrin
ether
Prior art date
Application number
ZA904599A
Other languages
English (en)
Inventor
Bruce E Haeger
E Haeger Bruce
James R Lawter
R Lawter James
Vijay H Naringrekar
H Naringrekar Vijay
Michael C Cucolo
C Cucolo Michael
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of ZA904599B publication Critical patent/ZA904599B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA904599A 1989-06-14 1990-06-13 Stable freeze dried polyhematoporphyrin ether/ester composition ZA904599B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/366,374 US5059619A (en) 1989-06-14 1989-06-14 Stable freeze-dried polyhematoporphyrin ether/ester

Publications (1)

Publication Number Publication Date
ZA904599B true ZA904599B (en) 1991-04-24

Family

ID=23442747

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904599A ZA904599B (en) 1989-06-14 1990-06-13 Stable freeze dried polyhematoporphyrin ether/ester composition

Country Status (26)

Country Link
US (1) US5059619A (cs)
EP (1) EP0402637B1 (cs)
JP (1) JP3112918B2 (cs)
KR (1) KR0164845B1 (cs)
CN (1) CN1058388C (cs)
AR (1) AR244549A1 (cs)
AT (1) ATE144703T1 (cs)
AU (1) AU625549B2 (cs)
CA (1) CA2018751C (cs)
CZ (1) CZ283309B6 (cs)
DD (1) DD295087A5 (cs)
DE (1) DE69029012T2 (cs)
DK (1) DK0402637T3 (cs)
ES (1) ES2095846T3 (cs)
FI (1) FI101597B1 (cs)
GR (1) GR3021511T3 (cs)
HU (1) HU215522B (cs)
IE (1) IE902137A1 (cs)
IL (1) IL94448A (cs)
NO (1) NO176645C (cs)
NZ (1) NZ233953A (cs)
PL (1) PL164744B1 (cs)
PT (1) PT94344B (cs)
RU (1) RU2019990C1 (cs)
TW (1) TW225475B (cs)
ZA (1) ZA904599B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5660181A (en) * 1994-12-12 1997-08-26 Physical Optics Corporation Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US5958104A (en) * 1997-09-11 1999-09-28 Nonomura; Arthur M. Methods and compositions for enhancing plant growth
CA2221912A1 (en) * 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
AU2085302A (en) 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for delivery of molecules into the cytosol
HU230334B1 (hu) 2000-11-29 2016-02-29 Pci Biotech As Vírus közreműködésével történő, a citoszolba irányuló molekulabevitelre szolgáló fotokémiai internalizáció és eljárás
US7175611B2 (en) 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
CN103961323B (zh) * 2013-02-05 2017-10-17 浙江海正药业股份有限公司 一种注射用hpph冻干粉针制剂及其制备方法
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2858320A (en) * 1956-04-02 1958-10-28 Baxter Laboratories Inc Stable hematoporphyrin
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
CA1291710C (en) * 1985-04-30 1991-11-05 Jerry C. Bommer Tetrapyrrole therapeutic agents
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy

Also Published As

Publication number Publication date
CN1047973A (zh) 1990-12-26
EP0402637B1 (en) 1996-10-30
TW225475B (cs) 1994-06-21
KR910000146A (ko) 1991-01-29
IL94448A (en) 1994-06-24
HU215522B (hu) 1999-01-28
CA2018751C (en) 2001-08-21
EP0402637A3 (en) 1991-04-03
PT94344B (pt) 1997-04-30
PT94344A (pt) 1991-02-08
IE902137A1 (en) 1991-01-02
NZ233953A (en) 1992-08-26
JP3112918B2 (ja) 2000-11-27
DK0402637T3 (da) 1997-04-07
IL94448A0 (en) 1991-03-10
AR244549A1 (es) 1993-11-30
JPH0331283A (ja) 1991-02-12
EP0402637A2 (en) 1990-12-19
AU5708990A (en) 1990-12-20
KR0164845B1 (ko) 1999-01-15
HUT54888A (en) 1991-04-29
ATE144703T1 (de) 1996-11-15
DE69029012D1 (de) 1996-12-05
CZ283309B6 (cs) 1998-02-18
NO902634L (no) 1990-12-17
DE69029012T2 (de) 1997-02-27
ES2095846T3 (es) 1997-03-01
IE902137L (en) 1990-12-14
CN1058388C (zh) 2000-11-15
DD295087A5 (de) 1991-10-24
FI101597B (fi) 1998-07-31
FI101597B1 (fi) 1998-07-31
PL164744B1 (pl) 1994-10-31
US5059619A (en) 1991-10-22
FI902966A0 (fi) 1990-06-13
CS9002889A2 (en) 1991-11-12
AU625549B2 (en) 1992-07-16
HU903850D0 (en) 1990-11-28
RU2019990C1 (ru) 1994-09-30
NO902634D0 (no) 1990-06-13
NO176645C (no) 1995-05-10
NO176645B (no) 1995-01-30
CA2018751A1 (en) 1990-12-14
GR3021511T3 (en) 1997-01-31

Similar Documents

Publication Publication Date Title
IL101007A (en) Dry stable compositions prepared by lyophilization
EP0423752A3 (en) Dielectric compositions
EP0412449A3 (en) Solid cosmetic composition
AR244549A1 (es) Metodo para preparar una composicion liolilizada con un contenido de humedad residual satisfactorio para el tratamiento o diagnostico fotodinamico de un paciente.
EP0428276A3 (en) Acaricidal composition
EP0425213A3 (en) Dry solid compositions containing lipid
GB2232428B (en) Surfactant composition
GB8908361D0 (en) Composition
HU900135D0 (en) New harbicid compositions
GB8904862D0 (en) Compositions
EP0386359A3 (en) Konjak-containing composition
GB8902762D0 (en) Surfactant composition
GB9028019D0 (en) All weather racetrack composition
GB2231575B (en) Command-curable composition
GB8916151D0 (en) Composition
GB8902894D0 (en) Compositions
GB2217175B (en) Dry solid compositions containing lipid
ZW9690A1 (en) Composition
ZA9010348B (en) Frying-fat composition
HU204716B (en) Raney-catalyzer composition
ZA9135B (en) All weather racetrack composition
GB8904789D0 (en) Dermatological composition
GB8917601D0 (en) Composition
GB8926563D0 (en) Composition
GB8922921D0 (en) Composition